| 04:30 PM |
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
|
| 05:19 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 04:00 PM |
Letter Of Offer For Buyback Of Up To 54,23,728 Fully Paid-Up Equity Shares Of The Company
|
| 06:31 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 10:37 AM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 04:01 PM |
Expanding Existing CMO Operations With Merck Sharpe & Dohme Singapore Trading Pte. Ltd By Theranym Biologics Private Limited, A Subsidiary Of The Company .
|
| 10:49 AM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 04:20 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 04:23 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 04:07 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:29 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 06:24 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 04:04 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 08:51 AM |
Intimation Of Record Date For Buyback
|
| 08:35 AM |
Transfer Of Company''s Domestic Branded Pharmaceutical Formulation Business To Auropharm Limited, A Wholly Owned Subsidiary Of The Company.,
|
| 08:24 AM |
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors - Buyback Of Shares
|
| 08:37 PM |
Board Meeting Intimation for To Consider, Inter Alia, A Proposal For Buyback Of The Fully Paid-Up Equity Shares Of The Company
|
| 05:36 PM |
Update On Solar Power Purchase Agreement And Acquisition Upto 26% Stake In Swarnaakshu Solar Power Private Limited.
|
| 12:05 PM |
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
|
| 04:53 PM |
Entry Into Marketing And Distribution Agreement For Biosimilars In EU Territories By Curateq Biologics Private Limited
|
| 05:44 PM |
Closure of Trading Window
|
| 09:57 AM |
Classification Of Unit-V Of Apitoria Pharma Limited, A Wholly Owned Subsidiary Of The Company As VAI By The US FDA
|
| 04:31 PM |
Classification Of Unit-II Of Eugia Pharma Specialities Limited, A Wholly Owned Subsidiary Of The Company As OAI By The US FDA
|
| 12:50 PM |
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 09:44 AM |
Classification Of Unit-IV Of APL Healthcare Limited, A Wholly Owned Subsidiary Of The Company As VAI By The US FDA - Reg.,
|
| 01:14 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 01:11 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 02:40 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 12:08 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 12:19 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 09:54 AM |
Clarification On Media Report, 'Aurobindo Pharma'S P Sarath Chandra Reddy Acquitted In Delhi Liquor Scam Case'.
|
| 06:16 PM |
Clarification sought from Aurobindo Pharma Ltd
|
| 04:15 PM |
Completion Of US FDA Inspection At Unit I Of Eugia Pharma Specialities Ltd
|
| 11:51 AM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 11:58 AM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 04:33 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 02:54 PM |
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
|
| 03:17 PM |
Intimation Of Orders Passed By The Goods & Services Tax Department
|
| 01:38 PM |
Clarification On News Item Appearing In Https://Www.Ndtvprofit.Com/"
|
| 11:53 AM |
Clarification sought from Aurobindo Pharma Ltd
|
| 11:17 AM |
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
|
| 06:34 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 11:43 AM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 11:51 AM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 10:04 PM |
Completion Of US FDA Inspection At Unit-VII Of Aurobindo Pharma Limited, Jedcherla
|
| 06:58 AM |
Announcement under Regulation 30 (LODR)-Investor Presentation
|
| 08:05 PM |
Announcement under Regulation 30 (LODR)-Restructuring
|
| 08:00 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 07:56 PM |
Announcement under Regulation 30 (LODR)-Change in Directorate
|
| 07:50 PM |
Announcement under Regulation 30 (LODR)-Investor Presentation
|
| 07:48 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 07:36 PM |
Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025
|
| 07:21 PM |
Board Meeting Outcome for Outcome Of Board Meeting
|
| 06:22 PM |
Completion Of US FDA Inspection At Unit III Of Eugia Pharma Specialities Ltd., A Wholly Owned Subsidiary Of The Company
|
| 12:02 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 12:00 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 10:27 AM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 10:07 AM |
Clarification On Significant Volume Movement In Company'S Shares
|
| 12:37 PM |
Clarification sought from Aurobindo Pharma Ltd
|
| 11:15 AM |
Clarification On Significant Volume Movement In Company'S Shares
|
| 04:43 PM |
Board Meeting Intimation for Intimation Of Board Meeting Date
|
| 05:09 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 03:19 PM |
Curateq Biologics Receives NOC From Health Canada For Its Biosimilar Dyrupeg
|
| 05:16 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 12:20 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 06:05 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 11:15 AM |
Announcement under Regulation 30 (LODR)-Updates on Acquisition
|
| 11:54 AM |
Curateq Biologics Private Limited, A Wholly Owned Subsidiary Of The Company Has Mutually Agreed To Terminate Its Agreement With Biofactura Inc, USA
|
| 11:59 AM |
Closure of Trading Window
|
| 01:28 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 10:06 AM |
Completion Of US FDA Inspection At Unit-IV Of APL Healthcare Limited, A Wholly Owned Subsidiary Of The Company
|
| 02:33 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 05:13 PM |
Completion Of US FDA Inspection At Unit-V Of Apitoria Pharma Private Limited, A Wholly Owned Subsidiary Of The Company
|
| 11:13 AM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 12:09 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 04:06 PM |
Completion Of US FDA Inspection At Unit II Of Eugia Pharma Specialities Ltd., Bhiwadi, A Wholly Owned Subsidiary Of The Company
|
| 11:49 AM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 10:31 AM |
Classification Of US FDA Inspection At Unit-I Of Apitoria Pharma Private Limited, A Wholly Owned Subsidiary Of The Company As Voluntary Action Indicated (VAI)
|
| 05:01 PM |
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
|
| 02:14 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 08:03 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 08:00 PM |
Announcement under Regulation 30 (LODR)-Investor Presentation
|
| 07:52 PM |
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 5, 2025
|
| 12:57 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 10:39 AM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 10:36 AM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 04:05 PM |
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On November 5, 2025 For Consideration Unaudited Financial Results For The Second Quarter & Half Year Ended On September 30, 2025.
|
| 09:53 AM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 09:49 AM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 12:51 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:20 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 12:19 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 12:00 PM |
Announcement under Regulation 30 (LODR)-Updates on Acquisition
|
| 06:14 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 05:30 PM |
Announcement under Regulation 30 (LODR)-Updates on Acquisition
|
| 03:54 PM |
Announcement under Regulation 30 (LODR)-Updates on Acquisition
|
| 12:32 PM |
Closure of Trading Window
|
| 01:24 PM |
Fire Accident At Unit-IV Of APL Healthcare Limited, A Wholly Owned Subsidiary Of The Company
|
| 10:19 AM |
Curateq Biologics Announces Successful Completion Of Phase 3 Clinical Study For Denosumab Biosimilar.
|
| 05:24 PM |
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
|
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback